Dr. Robin Jones on Olaratumab and Doxorubicin in Patients with Soft Tissue Sarcoma
3 Tampilan
• 07/18/23
0
0
Menanamkan
administrator
Pelanggan
Robin Jones, BSc, MB, MRCP, MD, oncologist, Royal Marsden Hospital, London, discusses the effectiveness of monoclonal antibody olaratumab in combination with doxorubicin in unresectable and metastatic soft tissue sarcoma.
For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/
Menampilkan lebih banyak
Komentar Facebook
SORT BY-
Komentar Teratas
-
komentar terbaru